The US Food and Drug Administration (FDA) has broadened the approved use of Amgen’s Repatha (evolocumab) to include adults at ...

The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

California, USA-based Protagonist Therapeutics yesterday revealed that its rusfertide, a potential first-in-class ...

Swedish drug developer BioArctic shot up 14.5% to 269.20 kronor on the news of a license and collaboration deal with Swiss ...

MannKind Corporation yesterday signed a definitive agreement to acquire fellow USA-based scPharmaceuticals, with the news ...

The Roche subsidiary Genentech has broken ground on its newest US production site in Holly Springs, North Carolina, marking ...

Russian drugmaker R-Pharm is searching buyers for its flagship factory in Germany in the city of Illertissen, which was ...

Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

The US eosinophilic esophagitis (EoE) market is projected to grow from $202 million in 2020 to $1.19 billion in 2030, ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

BeOne Medicines revealed it has entered into an agreement to sell its royalty rights on the worldwide sales, excluding China, of Amgen’s Imdelltra (tarlatamab-dlle) for up to $950 million to Royalty ...